AUDREY FULLER: Open Payments
NPI 1104462316 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 49 payments from 24 companies in 2025. Trend: 2023 $2,646 · 2024 $958 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 8 | $246 |
| CeQur Corporation | 1 | $184 |
| Xeris Pharmaceuticals, Inc. | 5 | $108 |
| Sequel Med Tech, LLC | 1 | $99 |
| Dexcom, Inc. | 5 | $95 |
| Amphastar Pharmaceuticals, Inc. | 3 | $50 |
| Abbott Laboratories | 3 | $49 |
| Lilly USA, LLC | 3 | $43 |
| Chiesi USA, Inc. | 2 | $41 |
| Ascendis Pharma Endocrinology Inc | 2 | $32 |
Products named: Omnipod, CeQur Simplicity, RECORLEV, TWIIST, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, MYCAPSSA, Yorvipath.
Industry payments across GA — which companies pay providers there.
